v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,665,508) $ (3,446,624)
Adjustments to reconcile net loss to net cash (used in) operating activities    
Depreciation and amortization 9,883 18,724
Stock based compensation - stock option grants 550,703 699,246
Issuance of common stock for services 0 26,250
Amortization of operating lease right-of-use asset 28,692 47,523
Loss on debt extinguishment (728,298) 0
Interest expense for repricing of warrants 233,644 0
Interest expense for extension of warrants 513,499 0
Amortization of debt issuance costs 386,762 0
Changes in operating assets and liabilities:    
Other long-term assets 0 (3,001)
Operating lease right-of-use liability (30,132) (48,759)
Accounts payable - trade and accrued expenses 345,733 (686,006)
NET CASH (USED IN) OPERATING ACTIVITIES (1,898,426) (3,392,647)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of research and development equipment 0 (12,697)
NET CASH (USED IN) INVESTING ACTIVITIES: 0 (12,697)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment of note payable (480,000) 0
Proceeds from issuance of common stock offering, net 300,000 203,105
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (180,000) 203,105
NET (DECREASE) IN CASH AND CASH EQUIVALENTS (2,078,426) (3,202,239)
CASH AND CASH EQUIVALENTS, beginning of period 3,110,755 8,023,716
CASH AND CASH EQUIVALENTS, end of period 1,032,329 4,821,477
Supplemental disclosures of cash flow information:    
Interest paid 39,000 0
Taxes paid 0 0
Supplemental disclosure of non-cash financing activity:    
Deemed dividends on Series C and D Preferred Stock 32,552 63,629
Common stock issued for debt payment 240,000 0
Repricing of convertible notes payable and warrants $ 1,302,607 $ 0

Source

10-Q PDF
XBRL